Most melanomas evolve through an initial stage known as radial growth
phase (RGP), encompassing in situ and microinvasive malignancies in wh
ich the probability of cure approaches 100%. At the present time, desp
ite a shift toward earlier recognition of melanoma, by the time of dia
gnosis roughly 70% of melanomas have evolved to a point, known as vert
ical growth phase (VGP) or tumorigenic melanoma, at which cure is not
certain, and prognosis depends upon certain attributes of the neoplasm
and the host. Attempts have been made to assemble these attributes in
to prognostic models to permit estimation of the probability of cure f
or individuals and for groups of patients. Attributes that have been i
dentified as independent prognostic variables include thickness of the
primary neoplasm, the numbers of mitotic figures, and the presence of
tumor-infiltrating lymphocytes (TIL). Other biologically important pr
ognostic variables are on the horizon, and some will likely be based o
n molecules (markers) expressed on neoplastic cells that show function
al significance in mechanisms of metastasis. Copyright (C) 1996 by W.B
. Saunders Company.